Welcome!
We are pleased to invite you to attend the 2019 Thrombosis Canada education conference, Thrombosis Management: Challenges, Controversies and Consensus 2019. The meeting will be held on Saturday, October 19, 2019 and features Canadian and international thrombosis experts. This program will cover a wide range of thrombosis-related topics relevant to your practice.
Target Audience:
Physicians, nurses and pharmacists involved in the management of patients with challenging medical or surgical conditions requiring personalized anticoagulant management.
Learning Objectives
After completing this program, participants will be equipped to:
- Incorporate the latest evidence into the management of patients with thrombotic disease
- Effectively manage thrombosis challenges in clinical practice
- Consider thrombosis treatment options for a variety of patient profiles.
Accreditation
This event is an accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians & Surgeons of Canada and approved by the Canadian Cardiovascular Society. You may claim a maximum of 5.5 hours.
This Group Learning program has been certified by the College of Family Physicians of Canada and the Ontario Chapter for up to 5.50 Mainpro+ credits.
The Canadian Council on Continuing Education in Pharmacy has accredited this program for 12.32 CEUs.
Accredited Breakfast symposium
In addition to the above program, with the support of BMS-Pfizer, we are pleased to present an accredited breakfast symposium entitled Paradigm Shift: Direct Oral Anticoagulants for the Prevention and Treatment of Cancer-Associated Thrombosis
Symposium objectives
After attending this program, participants will be better able to:
- Describe the rationale for primary thromboprophylaxis in ambulatory cancer patients;
- Apply data from recent clinical trials in clinical decision-making about primary thromboprophylaxis;
- Discuss direct oral anticoagulants in the treatment of cancer-associated thrombosis (CAT) recognizing cancer subgroups and bleeding risk.
Symposium accreditation
This event is an accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians & Surgeons of Canada and approved by the Canadian Cardiovascular Society. You may claim a maximum of 1 hour.
Please see the full agenda here: 2019 Conference Agenda
